Pegylated mechano growth factor (MGF), an IGF-1 splice variant peptide
PEG-MGF
Research use only
Written by pep4U Editorial Team · Last reviewed July 8, 2026
PEG-MGF is a longer-lasting, pegylated version of mechano growth factor, a muscle-specific splice variant of IGF-1.
| Class / type | Pegylated mechano growth factor (MGF), an IGF-1 splice variant peptide |
|---|
| Category | Growth Hormone & Muscle |
|---|
| Status (Jul 2026) | Research use only |
|---|
How it works
MGF (the IGF-1Ec E-peptide) activates quiescent muscle satellite (stem) cells to proliferate after mechanical stress or damage; attaching polyethylene glycol (PEG) extends its half-life from minutes to days.
Known / used for
Researched for muscle regeneration, tissue repair, and recovery from muscle damage; no approved clinical use exists.
Positives
Longer circulating half-life than native MGF, and studied potential to promote satellite cell proliferation and localized muscle repair.
Negatives & risks
No human clinical trials or established safety data, unknown long-term effects, theoretical tissue-growth and tumor-promotion concerns tied to IGF signaling, and product purity concerns in the research-chemical market.
What people like most (reported community sentiment - not endorsement)
Users report perceived improvements in muscle recovery and localized fullness; anecdotal sentiment only, not an endorsement.
Frequently asked questions
What is PEG-MGF?
PEG-MGF is a longer-lasting, pegylated version of mechano growth factor, a muscle-specific splice variant of IGF-1. MGF (the IGF-1Ec E-peptide) activates quiescent muscle satellite (stem) cells to proliferate after mechanical stress or damage; attaching polyethylene glycol (PEG) extends its half-life from minutes to days.
What is PEG-MGF used or researched for?
Researched for muscle regeneration, tissue repair, and recovery from muscle damage; no approved clinical use exists.
Is PEG-MGF FDA-approved or legal?
NOT FDA-approved. It is a research-only peptide with no pharmaceutical approval for human use and is prohibited by WADA at all times under class S2.
What are the main risks or downsides of PEG-MGF?
No human clinical trials or established safety data, unknown long-term effects, theoretical tissue-growth and tumor-promotion concerns tied to IGF signaling, and product purity concerns in the research-chemical market.
Legal / regulatory status
NOT FDA-approved. It is a research-only peptide with no pharmaceutical approval for human use and is prohibited by WADA at all times under class S2.
Recommended supplies
See all supplies →As an Amazon Associate we earn from qualifying purchases.
← Back to Growth Hormone & Muscle